Loading ...
Sorry, an error occurred while loading the content.

Plaque Psoriasis Research Study

Expand Messages
  • allenxvr
    Do you have plaque psoriasis? If so, you may be interested to know that a doctor in your area is conducting a clinical study to assess the safety and
    Message 1 of 2 , Jul 31, 2008
    View Source
    • 0 Attachment
      Do you have plaque psoriasis?

      If so, you may be interested to know that a doctor in your area is
      conducting a clinical study to assess the safety and effectiveness of
      a medication in patients with plaque psoriasis. In this study,
      patients will switch from Enbrel® to the study medication, which is
      FDA-approved to treat chronic severe plaque psoriasis but has not
      been studied in psoriasis patients who are switching treatments.

      To qualify for participation in this research study, you must:

      • Be between the ages of 18 and 75 years old
      • Have been diagnosed with plaque psoriasis
      • Have been treated with Enbrel® (etanercept) for at least the
      past 4 months
      • Currently have psoriatic lesions

      If you qualify and choose to participate in this study, you will
      receive an initial consultation, study-related examinations, and
      study medication at no cost to you. Compensation for travel may also
      be provided.

      To learn more, please visit our website at:
      www.PlaquePsoriasisStudy.com/index.asp?c=yg11
    • allenxvr
      Do you have plaque psoriasis? If so, you may be interested to know that a doctor in your area is conducting a clinical study to assess the safety and
      Message 2 of 2 , Dec 10, 2008
      View Source
      • 0 Attachment
        Do you have plaque psoriasis?

        If so, you may be interested to know that a doctor in your area is
        conducting a clinical study to assess the safety and effectiveness of
        a medication in patients with plaque psoriasis. In this study,
        patients will switch from Enbrel® to the study medication, which is
        FDA-approved to treat chronic severe plaque psoriasis but has not
        been studied in psoriasis patients who are switching treatments.

        To qualify for participation in this research study, you must:

        • Be between the ages of 18 and 75 years old
        • Have been diagnosed with plaque psoriasis
        • Have been treated with Enbrel® (etanercept) for at least the
        past 4 months
        • Currently have psoriatic lesions

        If you qualify and choose to participate in this study, you will
        receive an initial consultation, study-related examinations, and
        study medication at no cost to you. Compensation for travel may also
        be provided.

        To learn more, please visit our website at:
        www.PlaquePsoriasisStudy.com/index.asp?c=yg11
      Your message has been successfully submitted and would be delivered to recipients shortly.